Vascular response to acetazolamide decreases as a function of age in the arcA beta mouse model of cerebral amyloidosis.

Détails

ID Serval
serval:BIB_51ABF68E7CA6
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Vascular response to acetazolamide decreases as a function of age in the arcA beta mouse model of cerebral amyloidosis.
Périodique
Neurobiology of disease
Auteur(s)
Princz-Kranz F.L., Mueggler T., Knobloch M., Nitsch R.M., Rudin M.
ISSN
1095-953X (Electronic)
ISSN-L
0969-9961
Statut éditorial
Publié
Date de publication
10/2010
Peer-reviewed
Oui
Volume
40
Numéro
1
Pages
284-292
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
Deposition of beta-amyloid along cerebral vessels is found in most patients suffering from Alzheimer's disease. The effects of cerebral amyloid angiopathy (CAA) on the function of cerebral blood vessels were analyzed applying cerebral blood volume (CBV)-based fMRI to transgenic arcA beta mice. In a cortical brain region of interest (ROI), displaying high CAA, arcA beta mice older than 16 months showed reduced response to the vasodilatory substance acetazolamide compared to age-matched wild-type animals, both with regard to rate (vascular reactivity) and extent of vasodilation (maximal vasodilation). In a subcortical ROI, displaying little CAA, no genotype-specific decrease was observed, but maximal vasodilation decreased with age in arcA beta and wild-types. These findings indicate that vascular beta-amyloid deposits reduce the capacity of cerebral blood vessels to dilate upon demand, supporting the hypothesis that vascular beta-amyloid contributes to hypoperfusion and neurological deficits observed in AD and CAA. High diagnostic accuracy of the combined readouts in detecting vascular dysfunction in arcA beta mice was found.
Mots-clé
Acetazolamide, Aging/drug effects, Aging/genetics, Alzheimer Disease/diagnosis, Alzheimer Disease/genetics, Alzheimer Disease/metabolism, Amyloid beta-Protein Precursor/biosynthesis, Amyloid beta-Protein Precursor/genetics, Animals, Cerebral Amyloid Angiopathy/diagnosis, Cerebral Amyloid Angiopathy/genetics, Cerebral Amyloid Angiopathy/metabolism, Cerebral Arteries/drug effects, Cerebral Arteries/metabolism, Cerebral Cortex/blood supply, Cerebral Cortex/drug effects, Cerebrovascular Circulation/drug effects, Cerebrovascular Circulation/genetics, Disease Models, Animal, Genetic Markers, Humans, Mice, Mice, Transgenic, Predictive Value of Tests, Vasodilator Agents
Pubmed
Web of science
Création de la notice
25/05/2018 9:40
Dernière modification de la notice
23/08/2018 6:26
Données d'usage